Author: @admin

Post

Cidara Therapeutics to Present New Data at ASH 2018 Highlighting Potential of Rezafungin to Prevent Invasive Fungal Infections in Bone Marrow Transplant Patients

SAN DIEGO –(BUSINESS WIRE)–Nov. 27, 2018– Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that the company will present new data highlighting the potential of rezafungin to prevent invasive fungal READ FULL TEXT

November 27, 2018February 11, 2019by In News
Post

Melinta Therapeutics Granted European Commission Marketing Authorization for Vabomere® (meropenem and vaborbactam)

NEW HAVEN, Conn., Nov. 27, 2018 (GLOBE NEWSWIRE) — Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, today announced that the European Commission (EC) has approved Vabomere® (meropenem and vaborbactam) for use in adult patients with complicated intra-abdominal (cIAI) and urinary tract infections (cUTI), hospital-acquired...

November 27, 2018November 27, 2018by In News
Post

Amplyx Doses First Patient in Phase 2 Trial of APX001 in Patients with Candida Infection

SAN DIEGO – November 13, 2018 – Amplyx Pharmaceuticals, a company developing first-in-class products for life-threatening infections, today announced that the first patient has been dosed in the Company’s Phase 2 clinical program to evaluate the efficacy and safety of APX001 in the treatment of infections caused by Candida. “Initiating our Phase 2 program for...

November 13, 2018November 13, 2018by In News
Post

Summit Highlights Importance of Innovation in Fight Against Antibiotic Resistance During Antibiotics Awareness Week

Summit Therapeutics plc  (‘Summit’ or the ’Company’) Summit Highlights Importance of Innovation in Fight Against Antibiotic Resistance During Antibiotics Awareness Week Preclinical Data on New Mechanism Antibiotic SMT-571 for the Treatment of Gonorrhoea are the Focus of an Oral Presentation at the SCI/RSC Symposium on Antimicrobial Drug Discovery Oxford, UK, and Cambridge, MA, US, 12...

November 12, 2018November 12, 2018by In News